Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP831875.RA9AZ2Rf42OV3I3Rbl3jlOQx0O30zsUkkWpJkt1hLrqQk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP831875.RA9AZ2Rf42OV3I3Rbl3jlOQx0O30zsUkkWpJkt1hLrqQk130_assertion type Assertion NP831875.RA9AZ2Rf42OV3I3Rbl3jlOQx0O30zsUkkWpJkt1hLrqQk130_head.
- NP831875.RA9AZ2Rf42OV3I3Rbl3jlOQx0O30zsUkkWpJkt1hLrqQk130_assertion description "[We also compared molecular with cytomorphological findings in bone marrow/peripheral blood and tested this method of detection of IgH/BCL2 molecular marker in monitoring minimal residual disease (MRD) in routine clinical setting.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP831875.RA9AZ2Rf42OV3I3Rbl3jlOQx0O30zsUkkWpJkt1hLrqQk130_provenance.
- NP831875.RA9AZ2Rf42OV3I3Rbl3jlOQx0O30zsUkkWpJkt1hLrqQk130_assertion evidence source_evidence_literature NP831875.RA9AZ2Rf42OV3I3Rbl3jlOQx0O30zsUkkWpJkt1hLrqQk130_provenance.
- NP831875.RA9AZ2Rf42OV3I3Rbl3jlOQx0O30zsUkkWpJkt1hLrqQk130_assertion SIO_000772 20698113 NP831875.RA9AZ2Rf42OV3I3Rbl3jlOQx0O30zsUkkWpJkt1hLrqQk130_provenance.
- NP831875.RA9AZ2Rf42OV3I3Rbl3jlOQx0O30zsUkkWpJkt1hLrqQk130_assertion wasDerivedFrom befree-2016 NP831875.RA9AZ2Rf42OV3I3Rbl3jlOQx0O30zsUkkWpJkt1hLrqQk130_provenance.
- NP831875.RA9AZ2Rf42OV3I3Rbl3jlOQx0O30zsUkkWpJkt1hLrqQk130_assertion wasGeneratedBy ECO_0000203 NP831875.RA9AZ2Rf42OV3I3Rbl3jlOQx0O30zsUkkWpJkt1hLrqQk130_provenance.